Duloxetine vs Ipilimumab

Duloxetine vs Ipilimumab: Overview

This comparison examines the pharmacological differences between Duloxetine and Ipilimumab.

Mechanism of Action

Duloxetine: Serotonin-norepinephrine reuptake inhibitor (SNRI).

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Pharmacokinetics

Half-life: Duloxetine — 12 hours; Ipilimumab — 14.7 days.

Chemical Properties

Molecular Formula: Duloxetine — C18H19NOS.

Molecular Weight: Duloxetine — 297.4150 g/mol.

Type: Duloxetine — Small molecule; Ipilimumab — Antibody.